Results 1 to 10 of about 31,918 (237)

Febrile neutropenia following with single-low-dose methotrexate for the treatment of ectopic pregnancy: a case presentation

open access: goldThe Pan African Medical Journal, 2021
Methotrexate (MTX) is an effective, economical and safe drug used in the treatment of ectopic pregnancy. Complications are very rare. Herein, we reported a case of febrile neutropenia following single low-dose methotrexate for the treatment of ectopic ...
Burak Bayraktar
doaj   +2 more sources

Factors associated with hospital length of stay among cancer patients with febrile neutropenia. [PDF]

open access: goldPLoS ONE, 2014
PURPOSE:This study sought to evaluate factors associated with hospital length of stay in cancer patients with febrile neutropenia. METHODS:A prospective cohort study was performed at a single tertiary referral hospital in southern Brazil from October ...
Regis G Rosa, Luciano Z Goldani
doaj   +3 more sources

Analysis of antibiotics discontinuation during bone marrow suppression in childhood, adolescent and young adult patients with febrile neutropenia

open access: goldJournal of Microbiology, Immunology and Infection, 2021
Background: Antibiotics have been widely and efficaciously used for febrile neutropenia in pediatric patients. However, reports are scant regarding the risk factors for recurrent fever after discontinuation of antibiotics in a neutropenic state. Here, we
Ryoji Kobayashi   +6 more
doaj   +2 more sources

Carbapenems and febrile neutropenia [PDF]

open access: bronzeClinical Microbiology and Infection, 2017
International ...
Alfandari, S.   +2 more
openaire   +5 more sources

Mean Platelet Volume-to-Albumin Ratio as a Predictor of Mortality in Patients with Febrile Neutropenia: An Observational Study [PDF]

open access: goldMedicina
Background and Objectives: Febrile neutropenia (FN) is a life-threatening complication in cancer patients, necessitating early risk stratification for optimal management.
Jelena Dimitrijević   +3 more
doaj   +2 more sources

Population pharmacokinetics and optimized dosing of piperacillin-tazobactam in hematological patients with febrile neutropenia. [PDF]

open access: hybridAntimicrob Agents Chemother
Laporte-Amargos J   +16 more
europepmc   +2 more sources

Comprehensive evaluation of risk factors for the development and complications of chemotherapy-induced febrile neutropenia [PDF]

open access: yesSrpski Arhiv za Celokupno Lekarstvo, 2022
Febrile neutropenia is a serious adverse effect of chemotherapy. It can lead to complications and death, as well as delays in treatment, chemotherapy dose reductions, compromised treatment efficacy, and reduced survival.
Dimitrijević Jelena   +3 more
doaj   +1 more source

Prophylaxis and management of chemotherapy-induced febrile neutropenia: The role of myeloid growth factors [PDF]

open access: yesMedicinski Podmladak, 2022
Febrile neutropenia is a serious chemotherapy-related adverse event that can lead to complications and death and it could be a significant burden on the organization of the health care system.
Dimitrijević Jelena, Stojanović Marko
doaj   +1 more source

Febrile neutropenia in the emergency department

open access: yesCurrent Medical Issues, 2021
Introduction: Febrile neutropenia is one of the most common presentations to the emergency department. Identification and empirical antibiotic therapy improve the outcome of these patients.
Malle Simeon   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy